{
    "nct_id": "NCT05590624",
    "official_title": "Elucidating the Metabolic Impact of Isocaloric, Controlled, Mediterranean-Type Diets in Treatment-Naïve Men With Prostate Cancer on Active Surveillance (DINE Study)",
    "inclusion_criteria": "* Males ≥18 years old\n* High suspicion of prostate cancer (PCa) per urologist's clinical evaluation\n* BMI >18.5\n* No prior PCa diagnosis or hormonal therapy (-ies)\n* Ability to read, write, speak, and understand English\n* Ability to provide informed consent\n* Candidate for and elects active surveillance (AS) if diagnostic biopsy is positive\n* Willingness to consume provided dietary interventions\n* Adequate organ and marrow function: White blood cell count (WBC) ≥2,500/mcL, Absolute neutrophil count (ANC) ≥1,500/mcL, Platelets ≥100,000/mcL, Hemoglobin ≥9 g/dL (transfusions permitted), Total bilirubin ≤1.5 x the institutional upper limit of normal (ULN) (for subjects with Gilbert's disease ≤3.0 mg/dL), Aspartate aminotransferase (AST)/Alanine aminotransferase (ALT) ≤2.5 x institutional ULN, Creatinine clearance ≥51 ml/min as defined by Cockcroft-Gault equation\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Currently consuming a Mediterranean, lower carbohydrate, ketogenic, vegan, vegetarian, high fiber diet (14g fiber > per 1,000 Calories) and/or any supplements (including herbal), vitamins, minerals, that would interfere with diets being tested in the study as determined by dietitian and/or investigators.\n* Previous intolerability to fiber-rich diets\n* Colitis, Irritable Bowel Syndrome, or other gastrointestinal condition per clinician discretion\n* Unwilling to undergo transperineal PCa biopsies\n* Food allergies or other major dietary restrictions\n* Receiving active medical treatment for Type I or Type II diabetes mellitus\n* Prior antibiotic usage (i.e. within last 30 days) at time of consent\n* Recent weight loss (both intentional and unintentional) as defined by 5%+ body weight in the last 30 days\n* Undergone any type of weight loss surgery\n* Any medical contraindications as determined by investigators\n* High risk as defined by PSA≥20 and/or PI-RADS 5 lesion as per clinician evaluation\n* History of diabetic ketoacidosis\n* Gout\n* Patients that are immunosuppressed (transplant history, on immunosuppression, etc.) as per clinician discretion\n* Recent (within last 30 days) device implant/joint requiring antibiotics as per clinician determination\n* Prior history of prostate biopsy infection\n* Uncontrolled hypertension as defined by blood pressure greater than 140/80 (with or without medication)\n* Gallbladder removed or plan to remove per clinician evaluation\n* Other malignancies actively receiving systemic treatment as per clinician evaluation",
    "miscellaneous_criteria": ""
}